Results 161 to 170 of about 148,445 (286)
Molecularly imprinted polymeric nanocarriers (nanoMIPs) offer robust, antibody‐mimetic platforms to overcome the blood‐brain barrier. The article surveys nanoMIP design and ligand‐directed surface engineering that harness receptor‐mediated transcytosis, and highlights therapeutic and diagnostic applications in neurodegeneration, brain tumors and ...
Ranjit De, Shuliang Shi, Kyong‐Tai Kim
wiley +1 more source
Can Non-Neurosurgeons Operate on Traumatic Brain Injuries in Non-Metropolitan Areas? A Scoping Review. [PDF]
Bosley L, Gibbs C, Joo E, Dobson G.
europepmc +1 more source
Osteoclast‐Derived SLIT3 Mediates Osteoarthritis Pain and Degenerative Changes
In TMJ‐OA, osteoclasts play a significant role in promoting the growth of sensory nerves at the osteochondral interface. In early OA, TRAP+ osteoclast‐derived SLIT3 induces sensory nerve growth into the condylar cartilage. This nerve growth facilitates the development of pain associated with OA.
Weiwei Zhu +13 more
wiley +1 more source
Sickness absence > 14 days following sport-related traumatic brain injuries: a nationwide register-based study in Sweden. [PDF]
Oldenburg C +3 more
europepmc +1 more source
Recombinant Human Interleukin-1 Receptor Antagonist in Severe Traumatic Brain Injury: A Phase II Randomized Control Trial [PDF]
Adel Helmy +5 more
openalex +1 more source
Tracking physical impacts is important in many fields. Self‐assembled microparticles made from polydiacetylene and silk fibroin that change color from blue to red when hit can provide an alternative approach to traditional mechanical transducers, quantitatively visualizing impact with responses ranging from <100 to 770 N.
Marco Lo Presti +4 more
wiley +1 more source
Tumor necrosis factor‐α synthesis inhibitor, 3,6′‐dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice [PDF]
Renana Baratz +7 more
openalex +1 more source
“Time Is Brain” – for Cell Therapies
The concept that “time is brain” extends to stem cell therapy for stroke. Evidence across preclinical and clinical studies indicates that delivery timing shapes graft survival, integration, and efficacy by matching the evolving post‐stroke microenvironment.
Hao Yin +4 more
wiley +1 more source

